(Q36640675)

15 August 2017

1 reference

title

Glucocorticoids produce whole body insulin resistance with changes in cardiac metabolism (English)

1 reference

15 August 2017

1 reference

1 reference

Dake Qi

1

1 reference

PubMed ID

17077342

15 August 2017

Brian Rodrigues

series ordinal

2

1 reference

PubMed ID

17077342

15 August 2017

language of work or name

1 reference

31 October 2006

1 reference

American Journal of Physiology - Endocrinology and Metabolism

15 August 2017

1 reference

15 August 2017

292

1 reference

15 August 2017

3

1 reference

15 August 2017

E654-67

1 reference

Effects of the 11 beta-hydroxysteroid dehydrogenase inhibitor carbenoxolone on insulin sensitivity in men with type 2 diabetes.

15 August 2017

1 reference

https://api.crossref.org/works/10.1152%2FAJPENDO.00453.2006

Regulation of rat liver glucose-6-phosphatase gene expression in different nutritional and hormonal states: gene structure and 5'-flanking sequence

21 January 2018

1 reference

https://api.crossref.org/works/10.1152%2FAJPENDO.00453.2006

Routes of FA delivery to cardiac muscle: modulation of lipoprotein lipolysis alters uptake of TG-derived FA.

21 January 2018

1 reference

https://api.crossref.org/works/10.1152%2FAJPENDO.00453.2006

Cardiac myocyte apoptosis is associated with increased DNA damage and decreased survival in murine models of obesity

21 January 2018

1 reference

https://api.crossref.org/works/10.1152%2FAJPENDO.00453.2006

FoxO1 stimulates fatty acid uptake and oxidation in muscle cells through CD36-dependent and -independent mechanisms.

21 January 2018

1 reference

https://api.crossref.org/works/10.1152%2FAJPENDO.00453.2006

Mitogen-activated protein kinase (MAPK) phosphatase-1 and -4 attenuate p38 MAPK during dexamethasone-induced insulin resistance in 3T3-L1 adipocytes

21 January 2018

1 reference

https://api.crossref.org/works/10.1152%2FAJPENDO.00453.2006

Dose-response effect of elevated plasma free fatty acid on insulin signaling

21 January 2018

1 reference

https://api.crossref.org/works/10.1152%2FAJPENDO.00453.2006

Diabetic cardiomyopathy. A unique entity or a complication of coronary artery disease?

21 January 2018

1 reference

https://api.crossref.org/works/10.1152%2FAJPENDO.00453.2006

Peroxisome proliferator-activated receptor-gamma ligands inhibit adipocyte 11beta -hydroxysteroid dehydrogenase type 1 expression and activity

21 January 2018

1 reference

https://api.crossref.org/works/10.1152%2FAJPENDO.00453.2006

Dexamethasone induction of hypertension and diabetes is PPAR-alpha dependent in LDL receptor-null mice

21 January 2018

1 reference

https://api.crossref.org/works/10.1152%2FAJPENDO.00453.2006

Dexamethasone-induced insulin resistance shows no gender difference in healthy humans

21 January 2018

1 reference

https://api.crossref.org/works/10.1152%2FAJPENDO.00453.2006

Lipoprotein lipase in myocytes and capillary endothelium of heart: immunocytochemical study

21 January 2018

1 reference

https://api.crossref.org/works/10.1152%2FAJPENDO.00453.2006

Evidence for existence of tissue-specific regulation of the mammalian pyruvate dehydrogenase complex

21 January 2018

1 reference

https://api.crossref.org/works/10.1152%2FAJPENDO.00453.2006

Plasma binding proteins as mediators of corticosteroid action in vertebrates

21 January 2018

1 reference

https://api.crossref.org/works/10.1152%2FAJPENDO.00453.2006

Actions of insulin on the mammalian heart: metabolism, pathology and biochemical mechanisms

21 January 2018

1 reference

https://api.crossref.org/works/10.1152%2FAJPENDO.00453.2006

Plasma leptin and ghrelin in the neonatal rat: interaction of dexamethasone and hypoxia

21 January 2018

1 reference

https://api.crossref.org/works/10.1152%2FAJPENDO.00453.2006

Reduced cardiac efficiency and altered substrate metabolism precedes the onset of hyperglycemia and contractile dysfunction in two mouse models of insulin resistance and obesity.

21 January 2018

1 reference

https://api.crossref.org/works/10.1152%2FAJPENDO.00453.2006

Hyperglycemia-induced apoptosis in mouse myocardium: mitochondrial cytochrome C-mediated caspase-3 activation pathway

21 January 2018

1 reference

https://api.crossref.org/works/10.1152%2FAJPENDO.00453.2006

Lipoprotein lipase: cellular origin and functional distribution

21 January 2018

1 reference

https://api.crossref.org/works/10.1152%2FAJPENDO.00453.2006

Cloning of DGAT2, a second mammalian diacylglycerol acyltransferase, and related family members

21 January 2018

1 reference

https://api.crossref.org/works/10.1152%2FAJPENDO.00453.2006

Rapid actions of steroid receptors in cellular signaling pathways.

21 January 2018

1 reference

https://api.crossref.org/works/10.1152%2FAJPENDO.00453.2006

Corticosteroids inhibit cell death induced by doxorubicin in cardiomyocytes: induction of antiapoptosis, antioxidant, and detoxification genes

21 January 2018

1 reference

https://api.crossref.org/works/10.1152%2FAJPENDO.00453.2006

Transgenic expression of fatty acid transport protein 1 in the heart causes lipotoxic cardiomyopathy

21 January 2018

1 reference

https://api.crossref.org/works/10.1152%2FAJPENDO.00453.2006

A novel mouse model of lipotoxic cardiomyopathy

21 January 2018

1 reference

https://api.crossref.org/works/10.1152%2FAJPENDO.00453.2006

Cardiac lipid accumulation associated with diastolic dysfunction in obese mice.

21 January 2018

1 reference

https://api.crossref.org/works/10.1152%2FAJPENDO.00453.2006

In vivo effects of dexamethasone and sucrose on glucose transport (GLUT-4) protein tissue distribution

21 January 2018

1 reference

https://api.crossref.org/works/10.1152%2FAJPENDO.00453.2006

Adipose tissue compensates for defect of phosphatidylinositol 3'-kinase induced in liver and muscle by dietary fish oil in fed rats

21 January 2018

1 reference

https://api.crossref.org/works/10.1152%2FAJPENDO.00453.2006

Alterations in adult rat heart after neonatal dexamethasone therapy

21 January 2018

1 reference

https://api.crossref.org/works/10.1152%2FAJPENDO.00453.2006

Effects of glucocorticoid excess on the sensitivity of glucose transport and metabolism to insulin in rat skeletal muscle.

21 January 2018

1 reference

https://api.crossref.org/works/10.1152%2FAJPENDO.00453.2006

Differences in the regulation of adipose tissue and liver lipogenesis by carbohydrates in humans

21 January 2018

1 reference

https://api.crossref.org/works/10.1152%2FAJPENDO.00453.2006

Folding of the glucocorticoid receptor by the reconstituted Hsp90-based chaperone machinery. The initial hsp90.p60.hsp70-dependent step is sufficient for creating the steroid binding conformation

21 January 2018

1 reference

https://api.crossref.org/works/10.1152%2FAJPENDO.00453.2006

Regulation of the enzymes of hepatic microsomal triacylglycerol lipolysis and re-esterification by the glucocorticoid dexamethasone

21 January 2018

1 reference

https://api.crossref.org/works/10.1152%2FAJPENDO.00453.2006

Reduced adipose glucocorticoid reactivation and increased hepatic glucocorticoid clearance as an early adaptation to high-fat feeding in Wistar rats

21 January 2018

1 reference

https://api.crossref.org/works/10.1152%2FAJPENDO.00453.2006

Transport of steroid hormones: binding of 21 endogenous steroids to both testosterone-binding globulin and corticosteroid-binding globulin in human plasma

21 January 2018

1 reference

https://api.crossref.org/works/10.1152%2FAJPENDO.00453.2006

Lipoprotein lipase activity in rat cardiomyocytes is stimulated by insulin and dexamethasone

21 January 2018

1 reference

https://api.crossref.org/works/10.1152%2FAJPENDO.00453.2006

Diabetic cardiomyopathy: evidence, mechanisms, and therapeutic implications

21 January 2018

1 reference

https://api.crossref.org/works/10.1152%2FAJPENDO.00453.2006

Serum corticosteroid-binding globulin concentration and insulin resistance syndrome: a population study

21 January 2018

1 reference

https://api.crossref.org/works/10.1152%2FAJPENDO.00453.2006

A potential link between muscle peroxisome proliferator- activated receptor-alpha signaling and obesity-related diabetes

21 January 2018

1 reference

https://api.crossref.org/works/10.1152%2FAJPENDO.00453.2006

The cardiac phenotype induced by PPARalpha overexpression mimics that caused by diabetes mellitus

21 January 2018

1 reference

https://api.crossref.org/works/10.1152%2FAJPENDO.00453.2006

An approach to heart failure and diabetes mellitus

21 January 2018

1 reference

https://api.crossref.org/works/10.1152%2FAJPENDO.00453.2006

The glucocorticoid receptor gene is in 5q–q32

21 January 2018

1 reference

https://api.crossref.org/works/10.1152%2FAJPENDO.00453.2006

Lipoprotein lipase regulation by insulin and glucocorticoid in subcutaneous and omental adipose tissues of obese women and men.

21 January 2018

1 reference

https://api.crossref.org/works/10.1152%2FAJPENDO.00453.2006

Forkhead transcription factor FOXO1 (FKHR)-dependent induction of PDK4 gene expression in skeletal muscle during energy deprivation

21 January 2018

1 reference

https://api.crossref.org/works/10.1152%2FAJPENDO.00453.2006

Alterations in hepatic fine structure after chronic exposure of rats to dexamethasone

21 January 2018

1 reference

https://api.crossref.org/works/10.1152%2FAJPENDO.00453.2006

Glucocorticoid regulation of insulin receptor and substrate IRS-1 tyrosine phosphorylation in rat skeletal muscle in vivo

21 January 2018

1 reference

https://api.crossref.org/works/10.1152%2FAJPENDO.00453.2006

Corticosterone binding to tissues of adrenalectomized lean and obese Zucker rats.

21 January 2018

1 reference

https://api.crossref.org/works/10.1152%2FAJPENDO.00453.2006

Role of glucose transporters in glucocorticoid-induced insulin resistance. GLUT4 isoform in rat skeletal muscle is not decreased by dexamethasone

21 January 2018

1 reference

https://api.crossref.org/works/10.1152%2FAJPENDO.00453.2006

Acute cardiovascular protective effects of corticosteroids are mediated by non-transcriptional activation of endothelial nitric oxide synthase

21 January 2018

1 reference

https://api.crossref.org/works/10.1152%2FAJPENDO.00453.2006

Secretion of adiponectin and regulation of apM1 gene expression in human visceral adipose tissue

21 January 2018

1 reference

https://api.crossref.org/works/10.1152%2FAJPENDO.00453.2006

11beta-HSD1 inhibition ameliorates metabolic syndrome and prevents progression of atherosclerosis in mice

21 January 2018

1 reference

https://api.crossref.org/works/10.1152%2FAJPENDO.00453.2006

Functional antagonism between CCAAT/Enhancer binding protein-alpha and peroxisome proliferator-activated receptor-gamma on the leptin promoter

21 January 2018

1 reference

https://api.crossref.org/works/10.1152%2FAJPENDO.00453.2006

Hormone-Sensitive Lipase: Sequence, Expression, and Chromosomal Localization to 19 cent-q13.3

21 January 2018

1 reference

https://api.crossref.org/works/10.1152%2FAJPENDO.00453.2006

Regulation of pyruvate dehydrogenase complex activity by reversible phosphorylation

21 January 2018

1 reference

https://api.crossref.org/works/10.1152%2FAJPENDO.00453.2006

Regulation of pyruvate dehydrogenase kinase expression by peroxisome proliferator-activated receptor-alpha ligands, glucocorticoids, and insulin

21 January 2018

1 reference

https://api.crossref.org/works/10.1152%2FAJPENDO.00453.2006

Starvation and diabetes reduce the amount of pyruvate dehydrogenase phosphatase in rat heart and kidney

21 January 2018

1 reference

https://api.crossref.org/works/10.1152%2FAJPENDO.00453.2006

Prevalence of impaired glucose tolerance 6 years after gestational diabetes

21 January 2018

1 reference

https://api.crossref.org/works/10.1152%2FAJPENDO.00453.2006

National Cholesterol Education Program versus World Health Organization metabolic syndrome in relation to all-cause and cardiovascular mortality in the San Antonio Heart Study

21 January 2018

1 reference

https://api.crossref.org/works/10.1152%2FAJPENDO.00453.2006

Dietary trans-fatty acids alter adipocyte plasma membrane fatty acid composition and insulin sensitivity in rats

21 January 2018

1 reference

https://api.crossref.org/works/10.1152%2FAJPENDO.00453.2006

Hepatic glucocorticoid receptor antagonism is sufficient to reduce elevated hepatic glucose output and improve glucose control in animal models of type 2 diabetes

21 January 2018

1 reference

https://api.crossref.org/works/10.1152%2FAJPENDO.00453.2006

Lipoprotein lipase mRNA in white adipose tissue but not in skeletal muscle is increased by pioglitazone through PPAR-γ

21 January 2018

1 reference

https://api.crossref.org/works/10.1152%2FAJPENDO.00453.2006

Antidiabetic thiazolidinediones inhibit leptin (ob) gene expression in 3T3-L1 adipocytes

21 January 2018

1 reference

https://api.crossref.org/works/10.1152%2FAJPENDO.00453.2006

Overexpression of 11beta-hydroxysteroid dehydrogenase-1 in adipose tissue is associated with acquired obesity and features of insulin resistance: studies in young adult monozygotic twins

21 January 2018

1 reference

https://api.crossref.org/works/10.1152%2FAJPENDO.00453.2006

Adipocyte-specific glucocorticoid inactivation protects against diet-induced obesity

21 January 2018

1 reference

https://api.crossref.org/works/10.1152%2FAJPENDO.00453.2006

Active-dimeric form of lipoprotein lipase increases in the adipose tissue of patients with rheumatoid arthritis treated with prednisolone

21 January 2018

1 reference

https://api.crossref.org/works/10.1152%2FAJPENDO.00453.2006

Amelioration of high-fat feeding-induced insulin resistance in skeletal muscle with the antiglucocorticoid RU486.

21 January 2018

1 reference

https://api.crossref.org/works/10.1152%2FAJPENDO.00453.2006

Protein kinase B-alpha inhibits human pyruvate dehydrogenase kinase-4 gene induction by dexamethasone through inactivation of FOXO transcription factors

21 January 2018

1 reference

https://api.crossref.org/works/10.1152%2FAJPENDO.00453.2006

Effects of epoxyeicosatrienoic acids on the cardiac sodium channels in isolated rat ventricular myocytes.

21 January 2018

1 reference

https://api.crossref.org/works/10.1152%2FAJPENDO.00453.2006

Mitochondrial dysfunction in cardiac disease: ischemia--reperfusion, aging, and heart failure

21 January 2018

1 reference

https://api.crossref.org/works/10.1152%2FAJPENDO.00453.2006

Antisense oligonucleotides targeted against glucocorticoid receptor reduce hepatic glucose production and ameliorate hyperglycemia in diabetic mice

21 January 2018

1 reference

https://api.crossref.org/works/10.1152%2FAJPENDO.00453.2006

Subcutaneous adipose 11 beta-hydroxysteroid dehydrogenase type 1 activity and messenger ribonucleic acid levels are associated with adiposity and insulinemia in Pima Indians and Caucasians

21 January 2018

1 reference

https://api.crossref.org/works/10.1152%2FAJPENDO.00453.2006

Triglyceride accumulation protects against fatty acid-induced lipotoxicity

21 January 2018

1 reference

https://api.crossref.org/works/10.1152%2FAJPENDO.00453.2006

Cross talk between corticosteroids and alpha-adrenergic signalling augments cardiomyocyte hypertrophy: a possible role for SGK1.

21 January 2018

1 reference

https://api.crossref.org/works/10.1152%2FAJPENDO.00453.2006

Leptin activation of corticosterone production in hepatocytes may contribute to the reversal of obesity and hyperglycemia in leptin-deficient ob/ob mice

21 January 2018

1 reference

https://api.crossref.org/works/10.1152%2FAJPENDO.00453.2006

Is 11beta-hydroxysteroid dehydrogenase type 1 a therapeutic target? Effects of carbenoxolone in lean and obese Zucker rats

21 January 2018

1 reference

https://api.crossref.org/works/10.1152%2FAJPENDO.00453.2006

The antilipolytic effect of insulin in human adipocytes requires activation of the phosphodiesterase

21 January 2018

1 reference

https://api.crossref.org/works/10.1152%2FAJPENDO.00453.2006

Regulation of fatty acid oxidation in the mammalian heart in health and disease

21 January 2018

1 reference

https://api.crossref.org/works/10.1152%2FAJPENDO.00453.2006

Kinome analysis reveals nongenomic glucocorticoid receptor-dependent inhibition of insulin signaling

21 January 2018

1 reference

https://api.crossref.org/works/10.1152%2FAJPENDO.00453.2006

Cloning of the rat pyruvate dehydrogenase kinase 4 gene promoter: activation of pyruvate dehydrogenase kinase 4 by the peroxisome proliferator-activated receptor gamma coactivator

21 January 2018

1 reference

https://api.crossref.org/works/10.1152%2FAJPENDO.00453.2006

Factors associated with coronary artery calcification in young female patients with SLE.

21 January 2018

1 reference

https://api.crossref.org/works/10.1152%2FAJPENDO.00453.2006

11 Beta-hydroxysteroid dehydrogenase type 1 from human liver: dimerization and enzyme cooperativity support its postulated role as glucocorticoid reductase

21 January 2018

1 reference

https://api.crossref.org/works/10.1152%2FAJPENDO.00453.2006

A transgenic model of visceral obesity and the metabolic syndrome

21 January 2018

1 reference

https://api.crossref.org/works/10.1152%2FAJPENDO.00453.2006

Lipoprotein lipase: genetics, lipid uptake, and regulation.

21 January 2018

1 reference

https://api.crossref.org/works/10.1152%2FAJPENDO.00453.2006

Efficacy of steroid therapy for pacing failure in a patient with chronic myocarditis

21 January 2018

1 reference

https://api.crossref.org/works/10.1152%2FAJPENDO.00453.2006

Improved lipid and lipoprotein profile, hepatic insulin sensitivity, and glucose tolerance in 11beta-hydroxysteroid dehydrogenase type 1 null mice

21 January 2018

1 reference

https://api.crossref.org/works/10.1152%2FAJPENDO.00453.2006

Novel adipose tissue-mediated resistance to diet-induced visceral obesity in 11 beta-hydroxysteroid dehydrogenase type 1-deficient mice

21 January 2018

1 reference

https://api.crossref.org/works/10.1152%2FAJPENDO.00453.2006

Molecular determinants of crosstalk between nuclear receptors and toll-like receptors.

21 January 2018

1 reference

https://api.crossref.org/works/10.1152%2FAJPENDO.00453.2006

Unilateral adrenalectomy improves insulin resistance and diabetes mellitus in a patient with ACTH-independent macronodular adrenal hyperplasia

21 January 2018

1 reference

https://api.crossref.org/works/10.1152%2FAJPENDO.00453.2006

Stimulation of lipoprotein lipase synthesis by refeeding, insulin and dexamethasone

21 January 2018

1 reference

https://api.crossref.org/works/10.1152%2FAJPENDO.00453.2006

Inactivation of the glucocorticoid receptor in hepatocytes leads to fasting hypoglycemia and ameliorates hyperglycemia in streptozotocin-induced diabetes mellitus

21 January 2018

1 reference

https://api.crossref.org/works/10.1152%2FAJPENDO.00453.2006

Cardiac metabolism--emergence, decline, and resurgence. Part I

21 January 2018

1 reference

https://api.crossref.org/works/10.1152%2FAJPENDO.00453.2006

Cardiac metabolism--emergence, decline, and resurgence. Part II

21 January 2018

1 reference

https://api.crossref.org/works/10.1152%2FAJPENDO.00453.2006

Corticosteroid binding globulin: a new target for cortisol-driven obesity

21 January 2018

1 reference

https://api.crossref.org/works/10.1152%2FAJPENDO.00453.2006

Metabolic syndrome without obesity: Hepatic overexpression of 11beta-hydroxysteroid dehydrogenase type 1 in transgenic mice

21 January 2018

1 reference

https://api.crossref.org/works/10.1152%2FAJPENDO.00453.2006

Effect of dietary polyunsaturated fatty acids on age-related changes in cardiac mitochondrial membranes

21 January 2018

1 reference

https://api.crossref.org/works/10.1152%2FAJPENDO.00453.2006

Arachidonic acid cytotoxicity in leukocytes: implications of oxidative stress and eicosanoid synthesis

21 January 2018

1 reference

https://api.crossref.org/works/10.1152%2FAJPENDO.00453.2006

Diabetic cardiomyopathy: the search for a unifying hypothesis

21 January 2018

1 reference

https://api.crossref.org/works/10.1152%2FAJPENDO.00453.2006

Dopaminergic and Ligand-Independent Activation of Steroid Hormone Receptors

21 January 2018

1 reference

https://api.crossref.org/works/10.1152%2FAJPENDO.00453.2006

Cardiac lipoprotein lipase: metabolic basis for diabetic heart disease.

21 January 2018

1 reference

https://api.crossref.org/works/10.1152%2FAJPENDO.00453.2006

Single-dose dexamethasone induces whole-body insulin resistance and alters both cardiac fatty acid and carbohydrate metabolism

21 January 2018

1 reference

https://api.crossref.org/works/10.1152%2FAJPENDO.00453.2006

Adiponectin and resistin in the neonatal rat: effects of dexamethasone and hypoxia

21 January 2018

1 reference

https://api.crossref.org/works/10.1152%2FAJPENDO.00453.2006

The glucose fatty-acid cycle. Its role in insulin sensitivity and the metabolic disturbances of diabetes mellitus

21 January 2018

1 reference

https://api.crossref.org/works/10.1152%2FAJPENDO.00453.2006

Tissue-specific dysregulation of cortisol metabolism in human obesity

21 January 2018

1 reference

https://api.crossref.org/works/10.1152%2FAJPENDO.00453.2006

Banting lecture 1988. Role of insulin resistance in human disease

21 January 2018

1 reference

https://api.crossref.org/works/10.1152%2FAJPENDO.00453.2006

Antiinflammatory action of glucocorticoids--new mechanisms for old drugs

21 January 2018

1 reference

https://api.crossref.org/works/10.1152%2FAJPENDO.00453.2006

Hormonal regulation of mitochondrial energy production.

21 January 2018

1 reference

https://api.crossref.org/works/10.1152%2FAJPENDO.00453.2006

Myocardial substrate metabolism: implications for diabetic cardiomyopathy

21 January 2018

1 reference

https://api.crossref.org/works/10.1152%2FAJPENDO.00453.2006

Cardiac function in spontaneously hypertensive diabetic rats

21 January 2018

1 reference

https://api.crossref.org/works/10.1152%2FAJPENDO.00453.2006

The diabetic heart: metabolic causes for the development of a cardiomyopathy

21 January 2018

1 reference

https://api.crossref.org/works/10.1152%2FAJPENDO.00453.2006

The glucocorticoid receptor gene and its association to metabolic syndrome

21 January 2018

1 reference

https://api.crossref.org/works/10.1152%2FAJPENDO.00453.2006

21 January 2018

1 reference

https://api.crossref.org/works/10.1152%2FAJPENDO.00453.2006

Glucocorticoid-induced insulin resistance in skeletal muscles: defects in insulin signalling and the effects of a selective glycogen synthase kinase-3 inhibitor.

21 January 2018

1 reference

https://api.crossref.org/works/10.1152%2FAJPENDO.00453.2006

Expression and regulation of delta5-desaturase, delta6-desaturase, stearoyl-coenzyme A (CoA) desaturase 1, and stearoyl-CoA desaturase 2 in rat testis

21 January 2018

1 reference

https://api.crossref.org/works/10.1152%2FAJPENDO.00453.2006

Alteration in haemodynamics and pathological changes in the cardiovascular system during the development of Type 2 diabetes mellitus in OLETF rats

21 January 2018

1 reference

https://api.crossref.org/works/10.1152%2FAJPENDO.00453.2006

Glucocorticoids: do we know how they work?

21 January 2018

1 reference

https://api.crossref.org/works/10.1152%2FAJPENDO.00453.2006

Dexamethasone-induced insulin resistance in 3T3-L1 adipocytes is due to inhibition of glucose transport rather than insulin signal transduction

21 January 2018

1 reference

https://api.crossref.org/works/10.1152%2FAJPENDO.00453.2006

Transport of lipoprotein lipase across endothelial cells

21 January 2018

1 reference

https://api.crossref.org/works/10.1152%2FAJPENDO.00453.2006

The possible role of phospholipase A2 in cardiac membrane destabilization under calcium overload conditions

21 January 2018

1 reference

https://api.crossref.org/works/10.1152%2FAJPENDO.00453.2006

Mechanisms involved in the side effects of glucocorticoids

21 January 2018

1 reference

https://api.crossref.org/works/10.1152%2FAJPENDO.00453.2006

Arachidonic acid causes cell death through the mitochondrial permeability transition. Implications for tumor necrosis factor-alpha aopototic signaling

21 January 2018

1 reference

https://api.crossref.org/works/10.1152%2FAJPENDO.00453.2006

Development of insulin resistance in experimental animals during long-term glucocorticoid treatment

21 January 2018

1 reference

https://api.crossref.org/works/10.1152%2FAJPENDO.00453.2006

Low-dose dexamethasone in the rat: a model to study insulin resistance

21 January 2018

1 reference

https://api.crossref.org/works/10.1152%2FAJPENDO.00453.2006

Intramyocardial lipid accumulation in the failing human heart resembles the lipotoxic rat heart.

21 January 2018

1 reference

https://api.crossref.org/works/10.1152%2FAJPENDO.00453.2006

Obesity resistance and multiple mechanisms of triglyceride synthesis in mice lacking Dgat

21 January 2018

1 reference

https://api.crossref.org/works/10.1152%2FAJPENDO.00453.2006

Evolution of dexamethasone-induced insulin resistance in rats.

21 January 2018

1 reference

https://api.crossref.org/works/10.1152%2FAJPENDO.00453.2006

Gender differences in the associations between cortisol and insulin in healthy subjects.

21 January 2018

1 reference

https://api.crossref.org/works/10.1152%2FAJPENDO.00453.2006

Approach to treatment of the patient with metabolic syndrome: lifestyle therapy

21 January 2018

1 reference

https://api.crossref.org/works/10.1152%2FAJPENDO.00453.2006

Nutritional and hormonal regulation of enzymes in fat synthesis: studies of fatty acid synthase and mitochondrial glycerol-3-phosphate acyltransferase gene transcription

21 January 2018

1 reference

https://api.crossref.org/works/10.1152%2FAJPENDO.00453.2006

Diabetes-induced abnormalities in the myocardium

21 January 2018

1 reference

https://api.crossref.org/works/10.1152%2FAJPENDO.00453.2006

Weight loss increases 11beta-hydroxysteroid dehydrogenase type 1 expression in human adipose tissue

21 January 2018

1 reference

https://api.crossref.org/works/10.1152%2FAJPENDO.00453.2006

Expression of 11beta-hydroxysteroid dehydrogenase type 1 in adipose tissue is not increased in human obesity

21 January 2018

1 reference

https://api.crossref.org/works/10.1152%2FAJPENDO.00453.2006

mPPAR gamma 2: tissue-specific regulator of an adipocyte enhancer

21 January 2018

1 reference

https://api.crossref.org/works/10.1152%2FAJPENDO.00453.2006

Cardiac fatty acid uptake and transport in health and disease

21 January 2018

1 reference

https://api.crossref.org/works/10.1152%2FAJPENDO.00453.2006

Dexamethasone-induced impairment in skeletal muscle glucose transport is not reversed by inhibition of free fatty acid oxidation

21 January 2018

1 reference

https://api.crossref.org/works/10.1152%2FAJPENDO.00453.2006

PPARgamma agonists ameliorate endothelial cell activation via inhibition of diacylglycerol-protein kinase C signaling pathway: role of diacylglycerol kinase

21 January 2018

1 reference

https://api.crossref.org/works/10.1152%2FAJPENDO.00453.2006

Brown adipocytes are novel sites of expression and regulation of adiponectin and resistin

21 January 2018

1 reference

https://api.crossref.org/works/10.1152%2FAJPENDO.00453.2006

Peroxisome proliferator-activated receptor agonists modulate heart function in transgenic mice with lipotoxic cardiomyopathy

21 January 2018

1 reference

https://api.crossref.org/works/10.1152%2FAJPENDO.00453.2006

Atherosclerosis in premenopausal women with antiphospholipid syndrome and systemic lupus erythematosus: a controlled study.

21 January 2018

1 reference

https://api.crossref.org/works/10.1152%2FAJPENDO.00453.2006

The role of glucocorticoid action in the pathophysiology of the Metabolic Syndrome

21 January 2018

1 reference

https://api.crossref.org/works/10.1152%2FAJPENDO.00453.2006

An association between a Bc1I restriction fragment length polymorphism of the glucocorticoid receptor locus and hyperinsulinaemia in obese women

21 January 2018

1 reference

https://api.crossref.org/works/10.1152%2FAJPENDO.00453.2006

Ligand-independent activation of steroid hormone receptors

21 January 2018

1 reference

https://api.crossref.org/works/10.1152%2FAJPENDO.00453.2006

Synthesis and secretion of corticosteroid-binding globulin by rat liver. A source of heterogeneity of hepatic corticosteroid-binders

21 January 2018

1 reference

https://api.crossref.org/works/10.1152%2FAJPENDO.00453.2006

Increased glucocorticoid receptor expression in human skeletal muscle cells may contribute to the pathogenesis of the metabolic syndrome

21 January 2018

1 reference

https://api.crossref.org/works/10.1152%2FAJPENDO.00453.2006

Detection of human 11 beta-hydroxysteroid dehydrogenase isoforms using reverse-transcriptase-polymerase chain reaction and localization of the type 2 isoform to renal collecting ducts

21 January 2018

1 reference

https://api.crossref.org/works/10.1152%2FAJPENDO.00453.2006

The lipolysis/esterification cycle of hepatic triacylglycerol. Its role in the secretion of very-low-density lipoprotein and its response to hormones and sulphonylureas

21 January 2018

1 reference

https://api.crossref.org/works/10.1152%2FAJPENDO.00453.2006

Insulin resistance in idiopathic dilated cardiomyopathy: a possible etiologic link

21 January 2018

1 reference

https://api.crossref.org/works/10.1152%2FAJPENDO.00453.2006

Lipoprotein lipase (LpL) on the surface of cardiomyocytes increases lipid uptake and produces a cardiomyopathy

21 January 2018

1 reference

https://api.crossref.org/works/10.1152%2FAJPENDO.00453.2006

AMP-activated protein kinase: a key stress signaling pathway in the heart

21 January 2018

1 reference

https://api.crossref.org/works/10.1152%2FAJPENDO.00453.2006

Cardiac adverse effects of early dexamethasone treatment in preterm infants: a randomized clinical trial

21 January 2018

1 reference

https://api.crossref.org/works/10.1152%2FAJPENDO.00453.2006

Lipotoxic heart disease in obese rats: implications for human obesity

21 January 2018

1 reference

https://api.crossref.org/works/10.1152%2FAJPENDO.00453.2006

Effect of dexamethasone on adipocyte differentiation markers and tumour necrosis factor-alpha expression in human PAZ6 cells.

21 January 2018

1 reference

https://api.crossref.org/works/10.1152%2FAJPENDO.00453.2006

10.1152/AJPENDO.00453.2006

21 January 2018

Identifiers

DOI

1 reference

15 August 2017

1 reference

PubMed ID

17077342